COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with …

The COVID-19 pandemic has major implications for blood transfusion. There are uncertain
patterns of demand, and transfusion institutions need to plan for reductions in donations and …

Introduction There have been recent mounting concerns regarding multiple reports stating a
significantly elevated relative-risk of COVID-19 mortality amongst the Black and Minority …

Infections with SARS-CoV-2 can result in severe clinical manifestations. As such patients
present with systemic inflammation, we studied the prevalence and predictive value of …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has disrupted every aspect of
our life. The need to provide high-level care for an enormous number of patients with COVID …

The coronavirus disease 2019 (COVID-19) is an emerging infectious disease that has
become a global public health concern after being first reported in China and has …

Hydroxyurea is an antimetabolite drug that induces fetal haemoglobin in sickle cell disease.
However, its clinical usefulness in β-thalassaemia is unproven. We conducted a …

Diamond-Blackfan anemia (DBA) is a rare bone marrow failure syndrome, usually caused
by loss-of function variants in genes encoding ribosomal proteins. The hallmarks of DBA are …

Coronavirus disease 19 (COVID-19) has posed unparalleled challenges for healthcare
communities, the general population and, in particular, for patients suffering from various …

Abstract Introduction Coronavirus disease 2019 (COVID-19) is caused by the newly
identified strain of the coronavirus family that has been shown to affect the hemoglobin beta …